CompletedNCT01437046
Doxazosin or Placebo for Alcohol Use and Anxiety
About this title
Read the official source — NCT01437046Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Providence and 1 more locationSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: November 1, 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 41
- Sponsor
- Brown University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01437046
- Official title
Show the full official title
Doxazosin an a1 Antagonist for Alcohol Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Providence
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Brown University, a university.
Did this study involve medication?
Yes. The study involved medication, including Doxazosin and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
